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1. Introduction  
Patients with chronic pelvic pain frequently have pain from several pelvic organs. The most 
common diagnoses include endometriosis, interstitial cystitis, irritable bowel disease, pelvic 
floor tension myalgia, vulvar vestibulitis, and vulvodynia. Frequently, pain does not 
correlate with pathologic findings at the time of laparoscopy in the case of endometriosis, 
while vulvodynia, irritable bowel syndrome and pelvic floor tension myalgia and 
neuropathy may have no clearly demonstrable pathologic tissue changes. Most diagnoses 
associated with chronic pelvic pain have a high rate of recurrence and all are considered to 
be chronic conditions with a relapsing course. Endometriosis is a complex, poorly 
understood chronic illness of women in their reproductive age and pain is the major concern 
of women with this disease. Despite a successful reduction of pain using during the novel 
treatments pain returns in up to 75% of treated women. Pain is strongly associated with this 
disease and the lack of awareness to its pathology is further illustrated by the fact that the 
average time duration between the onset of pain and the diagnosis of endometriosis is 3 to 
11 years despite the fact that 25-30% of women with chronic pelvic pain suffer from this 
disease. In women with endometriosis (mainly of reproductive age) alterations in the limbic 
and sympathetic nervous system and hypothalamic-pituitary-adrenal axis mediate a cycle of 
hypervigilance for pain sensations from pelvic organs, which can lead to descending 
induction of pathologic changes in pelvic organs. Chronic pelvic pain patients frequently 
have multiple diagnoses. Vicero-somatic and viscero-viseral hyperalgesia and allodynia 
result in the spread of a perception of pain from an initial site to adjacent areas. Chronic 
pelvic pain patients may initially have only one pain source in the pelvis, such as the uterus 
in dysmenorrhea or endometriosis implants, but a multitude of mechanisms involving the 
peripheral and central nervous system can lead to the development of painful sensations 
from other adjacent organs. Often the etiology of visceral pain is not clear, as there are many 
symptoms of the reproductive system, gastrointestinal and urinary tracts, musculoskeletal, 
neurological   and psychological systems that often co-occur in the same patient. The 
variation of pain symptoms and pain perception and behavioral responses to pain in these 
patients is poorly understood. The treating clinician is often tempted to take a 
unidimensional approach and focus on one organ system and ignore the psychological and 
behavioral manifestations of the chronic pain. 
The incidence of persistent, episodic, or chronic visceral pain are more prevalent in females 
thus defining the site(s) and mechanisms through which female steroid hormones modulate 
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visceral nociception is an important step in understanding the gender differences in pain 
perception and in designing appropriate therapies for females. One such mechanism may be 
the convergence of nociceptive stimuli and estrogen input on the primary afferent neurons 
which innervate viscera. Based on our results, it is likely that estrogen receptors (ERs) 
expressed in primary afferent neurons modulate nociceptive signaling. Our recent data 
suggest that estrogen acting on primary afferent nociceptors modulates the response to pro- 
and anti-nociceptive signals associated with the clinical presentation of functional disorders 
such as endometriosis. 
1.2 The nociception of endometriosis 
Endometrial tissues outside the uterus can cause severe pain and this pain can be 
diminished with therapies that suppress estrogen production (Berkley et al. 2005). The 
mechanism of endometriosis-induced nociceptive signaling is poorly understood and in 
some cases pain can be exacerbated by co-morbidity with other chronic pelvic pain 
syndromes such as irritable bowel syndrome, painful bladder syndrome, vulvodynia and 
fibromyalgia. It has also been shown that ectopic implants develop sensory nerve supply 
both in women and in animal models of endometriosis. Sensory input arriving from the 
visceral organ to the spinal cord divergences at the level of primary sensory neurons which 
further transmit considerable information from periphery to the central nervous system. 
Visceral pain may be manifestation from a single organ such as uterus or may arise from 
algogenic conditions affecting more than one organ (Malykhina 2007). This type of pain is 
important not only because it is difficult to diagnose its clinical conditions but also for its 
therapeutic implications. It is quite possible to modulate pain from one viscus to another. 
Recent study by Giamberardino and others showed that the treatment of the endometriotic 
lesions results in the improvement of spontaneous and referred urinary symptoms 
(Giamberardino et al. 2010).  
Cross-sensitization in the pelvis implies the transmission of noxious stimuli from one organ to 
another through an adjacent normal structure resulting in functional (rarely organic) changes. 
Pelvic organ cross-sensitization is considered as one of the factors contributing to chronic 
pelvic pain (Pezzone et al. 2005). Chronic pelvic pain (CPP) syndrome affects up to 25% of 
reproductive age women and results in dysmenorrhea, menstrual irregularities, back pain and 
reduced fecundity. One of the most common causes of CPP is endometriosis. Chronic pain 
adversely affects mood, social and professional life and general well being.  Thus, assessing the 
impact of the pain on various domains of a patient’s existence has become an important focus 
in the clinical management. Most women with complaints of pelvic pain will undergo 
laparoscopy to both diagnose and treat these diseases, but laparoscopy is often is unsuccessful 
due to lack of intraperitoneal pathology or altered pain processing.  Pain out of proportion to 
identifiable pathology is the most immediate and dramatic consequence of disorders 
associated with CPP and is responsible for a highly negative impact on quality of life and 
substantial workforce loss. Results of a national survey determined that 15% of women in the 
United States have experienced CPP and only 10% of these consulted a gynecologist and 75% 
did not consult a health care provider of any type. Due to the alarming situation and unmet 
need, the USA and other countries have launched a call for more focused research on 
improving the diagnosis and treatment of CPP syndrome.  
There is often no clear relationship between the severity of the chronic pelvic pain and 
pathology in the pelvic viscera, including reproductive tract (ovaries and uterus). It is still 
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poorly understood how endometriosis is associated with pain symptoms in different organs 
and how this nociceptive signaling is ameliorated by a hypoestrogenic state. One of the 
possible explanation can be that endometrial implants’ sensory nerve supply and its 
potentially estradiol-modulated influence on the nociception.  
Several researchers have investigated the presence of nerve fibers in endometriotic lesions in 
both human and animal study. Using different types of specific immunohistochemical 
neuronal markers such as substance P (SP) and calcitonin gene related peptide (CGRP) 
sensory nerve fibers markers) in human peritoneal endometriotic lesions from women with 
visually and biopsy proven endometriosis, investigators have demonstrated multiple, small 
unmyelinated nerve fibers are present in peritoneal endometriotic lesions, and these 
peritoneal endometriotic lesions contain both Aδ and C nerve fibers. Accumulating evidence 
has shown these nerve fibers may play a critical role in pain production in patients with 
endometriosis, and a close histological relationship has been identified between these nerve 
fibers and endometriosis associated pain. Tulandi et al. (2001) reported that the distance 
between endometriotic glands and nerve fibers in endometriotic lesions from women with 
pain was closer than in women with no pain. The density of nerve fibers in peritoneal 
endometriotic lesions was much greater than in normal peritoneum in women with no 
endometriosis. The nerve fiber density in endometriotic lesions can be markedly reduced by 
hormonal drugs such as gonadotropin releasing hormone (GnRH) analogues and combined 
oral contraceptives, which have been used efficaciously to treat endometriosis-associated 
pain, indicating that modulation of these nerve fibers might alter pelvic nociception. The 
fact that peritoneal endometriotic lesions are innervated by sensory Aδ, sensory C nerve 
fibers raises the intriguing questions, what kind of role do these nerve fibers play in the 
mechanisms by which endometriotic lesions produce pain and hyperalgesia, and how do 
they modulate pain perception in these condition?  
The demonstration of Aδ and C sensory fiber innervations to peritoneal endometriotic 
lesions, suggesting these innervations contributes to both visceral hyperalgesia and pelvic 
pain that occur in patients with endometriosis brings up the interesting questions, how do 
these sensory fibers transmit and modulate visceral nociception in endometriosis?  
Immunohistochemical staining of these nerve fibers in endometriosis showed co-localization 
of SP, CGRP, implicating SP and CGRP might be involved in modulation of visceral 
nociception. Endometriosis is an inflammatory disease, which is known to contain pro-
inflammatory cytokines, prostaglandins, and other neuroactive agents that could readily 
activate the CGRP- and SP-positive C-fiber nociceptive afferents found in the endometriotic 
lesions.  
When these sensory nerve fibers are stimulated by inflammatory substances, 
neurotransmitters such as SP, CGRP can be secreted from sensory nerve endings. SP and 
CGRP can contribute to the inflammatory response by causing vasodilation, plasma 
extravasation and cellular infiltration by interacting with endothelial cells, arterioles, mast 
cells, neutrophils and immune cells. SP can also act on mast cells in the vicinity of sensory 
nerve endings to evoke de-granulation and the release of TNF-ǂ, histamine, prostaglandin 
D2 (PGD2) and leukotriene, providing a positive feedback. CGRP has a wide range of 
biological activities, including sensory transmission, regulation of glandular secretion, and 
inhibiting SP degradation by a specific endopeptidase to enhance SP release, thereby 
amplifying the effects.  
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Dorsal root ganglion (DRG) neurons can be activated or modulated by the activation of 
chemosensitive receptors on peripheral terminals and ATP has been implicated in sensory 
transduction of noxious stimuli by activating purinergic P2X receptors (Dunn et al. 2001). 
Once released into the intercellular areas, the action of ATP is mediated by primarily P2X3 
receptors which are expressed on primary afferent fibers and cell bodies within DRG 
(Burnstock 2001). The capsaicin-sensitive primary afferent neurons of small- and medium-
diameter neurons mediate nociceptive-like behaviors suggesting that TRPV1 expressing 
neurons are nociceptors. Activation of purinergic (P2X3) and  transient potential receptors 
family vcanilloid-1 (TRPV1) receptors results in the depolarization and opening of voltage-
gated Ca2+channels (VGCC) (Koshimizu et al. 2000). A sensation of pain is produced by 
depolarization of the peripheral nerve terminals.  
1.3 Estrogen receptors and nociceptive signaling in primary afferent neurons 
Defining the site(s) and mechanisms through which sex estrogen modulates visceral 
nociception is an important step in understanding the mechanisms in pain perception 
associated with endometriosis and in designing appropriate therapies. One such mechanism 
may be the convergence of nociceptive stimuli and estrogen input on the primary afferent 
neurons which innervate viscera (i.e. uterus). Estrogen may modulate female sensitivity to 
clinical and experimentally induced pain. Based on our preliminary results, it is likely that 
estrogen receptors (ERs) expressed in primary afferent neurons modulate chemical signaling 
associated with nociception. Nociception is a balance of pro- and anti-nociceptive inputs 
that is subject to regulation depending on the normal state of the organism. Sensitization of 
primary afferent neurons to stimulation may play a role in the enhanced perception of 
visceral sensation and pain.  Chest pain from coronary heart disease, endometriosis, acute 
and recurrent/chronic pelvic pain in women or abdominal are all visceral pain sensations 
that may result in part from sensitization (Berkley et al. 2001; Mayer et al. 2001).  
Mechanisms of peripheral sensitization may involve increased transduction that is 
secondary to repeated stimulation or an increase in the excitability of the afferent nerves by 
molecules that decrease the excitation threshold (Zimmermann 2001) 
The cell bodies of primary visceral spinal afferent neurons are located in DRG. Direct 
activation of chemosensitive receptors and ion channels on their peripheral terminals and 
modulation of neuronal excitability activates extrinsic primary afferent nerves. Nociceptors 
belong predominantly to small and medium size DRG neurons whose peripheral processes 
detect potentially damaging physical and chemical stimuli. The terminals of primary 
visceral afferent neurons are described as having no organs end or morphological 
specialization, but respond to different chemical stimuli. Visceral nociceptive C-fibers 
activated by ATP released by noxious stimuli from cells in target organs, have been 
implicated as mediators of noxious stimulus intensities (Burnstock 2000). Alteration in 
signal transduction of primary afferent neurons can result in enhanced perception of the 
visceral sensation that is common in patients with different disorders resulting in elevated 
pain perception. Acute and recurrent/chronic pelvic pain in women and abdominal pain 
from IBS are illustrative examples of visceral pain that undergo sensitization 
(Giamberardino et al. 2010).  
Peripheral sensitization can develop in response to sustain stimulation, inflammation, and 
nerve injury. Visceral pain is different from cutaneous pain based on clinical, 
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neurophysiological and pharmacological characteristics (Chang and Heitkemper 2002). The 
pathophysiology of visceral hyperalgesia is less well-known than its cutaneous counterpart, 
and our understanding of visceral hyperalgesia is colored by comparison to cutaneous 
hyperalgesia, which is believed to arise as a consequence of the sensitization of peripheral 
nociceptors due to long-lasting changes in the excitability of spinal neurons. Endometriosis 
is currently defined as a chronic functional syndrome characterized by recurring symptoms 
of abdominal discomfort or pain. In the context of visceral pain, the TRPV1 receptor is a 
sensory neuron-specific cation channel which plays an important role in transporting 
thermal and inflammatory pain signals. Evidence for TRPV1’s role is that mice lacking TRP1 
receptor gene have deficits in thermal- or inflammatory-induced hyperalgesia (Davis et al. 
2000). Activation of both TRPV1 and P2X receptors induce mobilization of [Ca2+]i in cultured 
DRG neurons (Gschossmann et al. 2000).  
Sex hormones and 17ǃ-estradiol (E2) in particular may directly influence the functions of 
primary afferent neurons since both ERs are present on small-diameter DRG neurons (Papka 
and Storey-Workley 2002). Despite the broad spectrum of E2 effects in the nervous system, the 
mechanisms of hormonal pain modulation remain unclear. There are two subforms: estrogen 
receptor-α (ERǂ) and estrogen receptor-β (ERǃ) which were traditionally thought of as ligand-
activated transcription factors. However, recent work has demonstrated multiplicity of E2 
actions (membrane, cytoplasmic and nuclear) (Nadal et al. 2001). ER distributed through CNS 
and PNS including regions that mediate nociception. For example, ERs are expressed in dorsal 
horn neurons of the spinal cord and DRG neurons. DRG neurons express both ERǂ and ERǃ in 
vivo (Papka and Storey-Workley 2002) and in vitro (Chaban 2010). These findings suggest that 
E2 may modulate sensory input at the primary afferent level. E2 can alter gene transcription, 
resulting in pro-nociceptive (reducing ǃ-endorphin expression) or anti-nociceptive (increasing 
enkephalin expression) changes of endogenous opioid peptides , opioid receptors (Micevych 
and Sinchak 2001) and, by increasing levels of CCK, an anti-nociceptive and anti-opioid 
molecule (Micevych et al. 2002).  
E2 can modulate cellular activity by altering ion channel opening and second messenger 
signaling by stimulating G-proteins (Chaban et al. 2003) , the signal transduction pathways 
traditionally associated with membrane receptor activation. Many of these effects have been 
ascribed to membrane-associated receptors. The results from other laboratories (Lee et al. 
2002) and our data (Chaban  et al. 2003) indicate that E2 is acting to modulate L-type VGCC. 
The cloned TRPV1 receptor is a nonselective cation channel with a high permeability for 
Ca2+. TRPV1’s are distributed in peripheral sensory nerve endings and are involved in the 
transduction of different stimuli in sensory neurons. TRPV1 functions as molecular 
integrator of painful chemical and physical stimuli (noxious heat (>43º C) and low pH). 
Various inflammatory mediators such as prostaglandin E2 (PGE2) and bradykinin potentiate 
TRPV1. The potentiation of TRPV1 activity can be quantified by measuring the differences 
of capsaicin-induced  Ca2+ concentration changes before and after receptor activation 
(Petruska et al. 2000). Significantly, a subset of DRG neurons respond to both capsaicin and 
ATP  indicating that there may be cross-activation of these receptors that may underlie the 
sensitization of visceral nociceptors. Capsaicin-induced TPRV1 receptor-mediated changes 
in [Ca2+]i may represent a level of DRG activation to noxious cutaneous stimulation while 
ATP-induced changes in [Ca2+]i may reflect the level of DRG neuron sensitization to noxious 
visceral stimuli since ATP is released by noxious stimuli and tissue damage near the 
primary afferent nerve terminals (Burnstock 2001).  
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Most of the published reports about sex and hormone-related differences in pain have 
addressed the modulatory effect of E2 on central nervous system  mechanisms of 
nociception (Aloisi et al. 2000). Recent studies demonstrate that E2 has a significant role in 
modulating viscerosensitivity, indicating that E2-induced alterations in sensory processing 
may underlie sex-based differences in functional pain syndromes (Al-Chaer and Traub 
2002). However, reports of E2 modulation of visceral and somatic nociceptive sensitivity are 
inconsistent. For example, elevated E2 levels have been reported to increase the threshold to 
cutaneous stimuli but decrease the percentage of escape responses to ureteral calculosis 
(Bradshaw and Berkley 2002). Additionally, nociceptive sensitivity increases when E2 levels 
are elevated (Holdcroft 2000; Bereiter 2001). Indeed in most clinical studies, women report 
more severe pain levels, more frequent pain and longer duration of pain than men. To help 
resolve these inconsistencies we propose to study E2 actions on the primary afferents.  
Primary DRG neurons culture has been a useful model system for investigating sensory 
physiology and putative nociceptive signaling (Chaban et al. 2003). ATP-induced 
intracellular calcium concentration ([Ca2+]i) transients in cultured DRG neurons have been 
used to model the response of nociceptors to painful stimuli.  In our laboratory we showed 
that E2, acting at the level of the plasma membrane, attenuates both ATP -induced [Ca2+]і 
and capsaicin- induced [Ca2+]i influx and that the expression of both P2X3 and TRPV1 
depend on the expression of both ERs. Within the context of our hypothesis visceral 
nociception and nociceptor sensitization appear to be regulated by P2X3 and TRPV1.  
Estrogen attenuates DRG neurons response to ATP and capsaicin suggesting that visceral 
afferent nociceptors can be modulated by sex steroids at a new site at the level of primary 
afferent neurons. Our data suggest that E2 by itself appears to be anti-nociceptive but 
interferes with anti-nociceptive actions of other pain-modulating drugs (such as opioids). 
Thus, E2 acting on primary afferent nociceptors modulates the response to pro- and anti-
nociceptive signals. Within the context of our cross-sensitization hypothesis, inflammation 
sensitizes non-inflamed viscera that are innervated by the same DRG and/or cross-
sensitization occurs as a result of intra-DRG release of sensitizing mediators such as ATP or 
substance P in the DRG (Matsuka et al. 2001; Chaban 2008; Chaban 2010).  
Lumbosacral DRG neurons (levels L6-S1) from wild type mice (WT) express estrogen 
receptors (ERǂ and ERǃ), purinergic P2X3, vanilloid TRPV1, SP and methabotropic 
glutamate (mGluR2/3) receptors. In our recent studies we also tested the difference in how 
somatic and visceral afferents are modulated by E2. Both short-term and long-term exposure 
to E2 significantly decreased the ATP and capsaicin-induced increase in [Ca2+]i.  
2. Materials and methods 
2.1 Animals 
We have used 6~8 week female C57BL/6J, B6.129P2-Esr1tm1Ksk/J, and B6.129P2-Esr2tm1Unc/J 
mice were obtained the Jackson Laboratory (Bar Harbor, ME, USA). Upon arrival, mice were 
group housed in microisolator caging and maintained on a 12-h light/dark cycle in a 
temperature-controlled environment with access to food and water ad libitum. To test 
whether estrogen receptor ǂ (ERǂ) or estrogen receptor ǃ (ERǃ) are involved in estradiol 
(E2)-induced modification of [Ca2+]і Wile type, estrogen receptor alpha knock-out (ERǂKO) 
and estrogen receptor beta knock-out (ERǃKO) mice will be used. The wild type, ERǂKO 
and ERǃKO mice will be obtained from the supplier and allowed to recover for two weeks. 
These studies were carried out in accordance with the guidelines of the Institutional Animal 
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Care and Use committee at the University of California and the NIH Guide for the Care and 
Use of Laboratory Animals. 
2.2 Animal breeding 
Experiments were performed on age-matched (8–10 wk old) heterozygous mutant mice 
lacking the gene male (ERǂ−/−) and female (ERǂ−/−) for ERǂ (ERǂ−/−), and the deficiency 
ERǃ (ERǃ−/−) mice were bred into heterozygous mutant  female mice (ERǃ−/−) and 
homozygous male mutant mice (ERǃ−/−) (Jackson Laboratory, Bar Harbor, ME, USA). Mice 
were housed in climate-controlled rooms, and standard rodent chow and water were 
available ad libitum and were housed in accordance with the NIH Guide for the Care and 
Use of Laboratory Animals  
2.3 Primary culture of DRG neurons 
The isolation procedure and primary culture of mouse lumbosacral DRG has been 
published in detail (Chaban, Mayer et al. 2003). DRG tissues were obtained from c57/black 
6J (The Jackson Laboratory; 30 g), ERǂKO and ERǃKO (Taconic; 20 g) transgenic types.  
Briefly, lumbosacral adult DRGs (level L1-S1) from Wt, ERǂKO and ERǃKO mice will be 
collected under sterile technique and placed in ice-cold medium Dulbecco’s Modified 
Eagle’s Medium (DMEM; Sigma Chemical Co., St. Louis, MO). Adhering fat and connective 
tissue will be removed and each DRG will be minced with scissors and place immediately in 
a medium consisting of 5 ml of DMEM containing 0.5 mg/ml of trypsin (Sigma, type III), 1 
mg/ml of collagenase (Sigma, type IA) and 0.1 mg/ml of DNAase (Sigma, type III) and kept 
at 37°C for 30 minutes with agitation. After dissociation of the cell ganglia, soybean trypsin 
inhibitor (Sigma, type III) will be used to terminate cell dissociation. Cell suspension will be 
centrifuged for one minute at 1000 rpm and the cell pellet will be resuspended in DMEM 
supplemented with 5% fetal bovine serum, 2 mM glutamine-penicillin-streptomycin 
mixture, 1 μg/ml DNAase and 5 ng/ml NGF (Sigma). Cells will be plated on Matrigel® 
(Invitrogen)-coated 15-mm coverslips (Collaborative Research Co., Bedford, PA) and kept at 
37° C in 5% CO2 incubator for 24 hrs, given fresh media and maintained in primary culture 
until used for experimental procedures. 
2.4 Western blot analysis 
The expressions of TRPV1 and of P2X3 receptors in L1~S1 DRGs were studied by using 
Western blot analyses. Tissues from wild type (C57BL/6J), ERǂKO, and ERǃKO mice were 
quick frozen in tubes on dry ice during collection. L1~S1 DRG were combined, 
homogenized by mechanical disruption in ice-cold RIPA buffer plus protease inhibitors and 
incubated on ice for 30 minutes. Homogenates were then spun at 5000 g for 15 minutes and 
supernatants collected. Total protein was determined on the supernatants using the BCA 
microtiter method (Pierce, Rockford, Ill., USA). Samples containing equal amounts of 
protein (40µg) were electrophoresed under denaturing conditions using Novex Mini-cell 
system (San Diego, Calif., USA) and reagents (NuPage 4–12% Bis-Tris gel and MOPS 
running buffer). After electrophoretic transfer onto nitrocellulose membrane using the same 
system, the membrane was blocked with 5% non-fat dry milk (NFDM) in 25 mM TRIS 
buffered saline, pH 7.2, plus Tween 20 (TBST) for 1 hour at room temperature, followed by 
incubation with polyclonal rabbit antibody against TRPV1-N terminus (1:1000, Neuromics) 
and P2X3 receptor (1:1000, Neuromics) for overnight at 4oC. The membrane was then 
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washed in TBST plus NFDM, and incubated with secondary antibody, HRP conjugated and 
rabbit IgG (Santa Cruz Biotechnology) at 1:5,000 in the same buffer for 2 hours at room 
temperature. Following a final wash in TBST without NFDM, the membrane was incubated 
with ECL+ (Amersham, Arlington Heights, Ill., USA) substrate for HRP. Membranes were 
probed with primary antibody and corresponding secondary antibodies, signals were 
scanned and quantified by Image J version 1.28U and NIH Image 1.60 scan software. 
Following enhanced chemiluminescence (ECL) detection of proteins, the membranes were 
stripped and rehybridized with ǃ-actin antibody as a loading control. At least three 
independent cell preparations were used. 
2.5 Immunohistochemistry (IHC) 
DRG tissues were obtained from C57/black 6J (The Jackson Laboratory; 30 g), ERǂKO and 
ERǃKO (Taconic; 20 g) transgenic types.  Following decapitation, DRG from bilateral spinal 
levels L1-S2 were removed and fixed in 4% paraformaldehyde for overnight at 4oC, according 
to procedures approved by National Institutes of Health policy on Humane Care and Use of 
Laboratory Animals.  DRGs were rinsed in Delbecco’s Phosphate Buffered Saline (DPBS) 
before cryoprotection in sucrose (20%, 4oC) for two days, after which excess liquid was 
removed. DRG were quick snap frozen in 2-methylbutane, and store them at -70oC. Each DRG 
was mounted in Tissue-Tek® OCT embedding medium (Sakura Finetek), and sectioned at -
20oC in a MICROM H505E cryostat. Sections were cut at 20µm and store 4oC until required. 
Sections of DRGs were collected in PBS. Endogenous tissue peroxidase activity was quenched 
by soaking the sections for 10 min in 3% hydrogen peroxide solution in 0.01 M PBS. The 
specimens were washed and then treated for 60 min in blocking solution, 0.01 M PBS 
containing 0.5% Triton X-100 and 1% normal donkey serum (NDS) at room temperature. They 
were processed for wild type (n=4), ERǂKO (n=4), or ERǃKO (n=4) immunohistochemistry by 
the free floating method using polyclonal rabbit TRPV1 antibody (1:50000, Neuromics) or 
P2X3 receptor antibody (1:15000, Neuromics) for overnight at 4oC, washed in 0.01 M 
phosphate-buffered saline (PBS) and 0.01M Tris Buffered Saline (TBS), followed by incubation 
in solutions of donkey anti-rabbit fluorophore-conjugated secondary antibodies (1:200, 
Invitrogen) in 0.01M Tris Buffered Saline (TBS) for 3 hours at room temperature. Cells showing 
no apparent or only faint membrane ⁄ intracellular labeling were considered to be negative for 
TRPV1 or P2X3. TRPV1-positive cells included those with strong plasma membrane labeling 
that formed a discernible clustered pattern, and those with strong intracellular labeling that 
formed a punctuate pattern. Some neurons showed both strong plasma membrane and 
intracellular labeling. P2X3-positive neurons showed diffuse membrane⁄ intracellular labeling. 
Mounted sections were air dried and coverslipped with Aqua Poly Mount (Polisciences, 
Warrington, PA). Images from at least three sections in each level were taken using Leica 
DMLB M130X microscope. The total numbers of DRG neurons expressing TRPV1 and P2X3 
were counted. TRPV1- or P2X3-positive neurons were categorized according to their labeling 
patterns and were expressed as a percentage of the total number of TRPV1- or P2X3-positive 
cells. Immunohistochemical signal percent was measured by computerized image analysis 
(Image Pro-Plus, Media Cybernetics, Silver Spring, MD, USA). 
2.6 [Ca
2+
]i fluorescence imaging 
Ca2+ fluorescence imaging was carried out as previously described (Gschossmann et al. 2000, 
Chaban et al. 2001). DRG neurons were loaded with fluorescent dye Fura-2 AM  (Invitrogen) 
for 45 min  at 37°C in HBSS supplemented with 20 mM HEPES, pH 7.4. The coverslips will be 
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mounted on a fast-perfusion chamber P-4 (World Precision Instrument) and placed on a stage 
of Olympus IX51 inverted microscope. Observations were made at room temperature (20-
23°C) with 20X UApo/340 objective. A fast superfusion system will be used to perfuse the cells 
with HBSS and rapidly apply E2 and other chemicals. Fluorescence intensity at 505 nm with 
excitation at 334 nm and 380 nm was captured as digital images (sampling rates of 0.1-2 s). 
Regions of interest were identified within the soma or neuritis from which quantitative 
measurements will be made by re-analysis of stored image sequences using Slidebook® Digital 
Microscopy software. [Ca2+]i was determined by ratiometric method of Fura-2 fluorescence 
from calibration of series of buffered Ca2+ standards. We applied E2 acutely for five minutes 
onto the experimental chamber or the culture medium for 48 hours to study the prolonged 
effect of E2. Repeated applications of drugs were achieved by superfusion in a rapid mixing 
chamber into individual neurons for specific intervals (100-500 ms). Cells were perfused with 
experimental media (2 ml/min) using a Rainin® peristaltic pump. 
2.7 Retrograde labeling 
DRG neurons innervating viscera were identified by retrograde labeling. Briefly, mice were 
anesthetized with isoflurane. For colonic afferents, the descending colon was exposed and 
Fluorogold (5% solution in PBS; Molecular Probes, Eugene, OR) was injected into the 
intestinal muscle wall (10 µl injections of into five to six different sites) using a Hamilton 
syringe (Hamilton Co., Reno, NV) with a 26-gauge needle. In another experiments we used 
uterus-specific DRG neurons in which tetramethylrhodamine (TMR) dye was injected in the 
uterus. Injection sites were carefully swabbed, the colon and uterus were extensively rinsed 
with 0.9% sodium chloride solution and sealed with New Skin to prevent dye leakage. The 
abdomen was sutured and the animals monitored for signs of pain or discomfort during the 
survival period. All animals were allowed to survive one week to allow for maximal 
transport of retrograde markers and housed in groups of two under 12/12 hours light cycle 
with food and water available ad libitum.     
2.8 Statistical analysis 
The amplitude of [Ca2+]i response represents the difference between baseline concentration 
and the transient peak response to drug stimulation. Significant differences in response to 
chemical stimulation will be obtained by comparing [Ca2+]i increases during the first 
stimulation with the second. A cell will be judged responsive if E2 inhibits the second [Ca2+]i 
transient by >30% of the first. This criterion was empirically derived in preliminary 
experiments. All of the data are expressed as the mean ± SEM. Statistical analysis was 
performed using Statistical Package for the Social Sciences 12.0 (SPSS, Chicago, IL, USA). To 
assess the significance among different groups, data were analyzed with one-way ANOVA 
followed by Schéffe post hoc test. A P <0.05 was considered statistically significant. 
3. Results  
3.1 Role of P2X3 receptors in estrogen-induced nociceptive signaling in sensory 
neurons 
P2X3 and TRPV1 receptors expression were examined by western blot analysis of lysates from 
wild type, ERǂKO, and ERǃKO DRG tissues using a P2X3 specific primary antiserum (Fig.1 
(a)). An intense band representing a ~64 kDa protein (P2X3) and a ~130 kDa (TRPV1) was seen 
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in DRG lysates from wild type animals. There was a dramatic decrease in intensity of this band 
using lysates made from the both knock out DRG tissues when compared with wild type 
control animals (>4 fold decrease of control Fig.1). When the density in the control group was 
standardized to 1.0, the average densities were 0.172 ± 0.08 of ERǂKO and 0.262 ± 0.10 of 
ERǃKO in P2X3 receptors, and 0.59 ± 0.06 of ERǂKO and 0.391 ± 0.04 of ERǃKO in TRPV1 
receptors, suggesting that both P2X3 and TRPV1 protein decreased in DRG, P<0.05, n=10.  
 
Fig. 1. Western blot analysis of DRG lysates shows reduced expression of P2X3 and TRPV1 
in both knock-out mice.  
Our study show that nociceptive capsaicin-sensitive TRPV1 receptors and ATP-sensitive 
P2X3 receptors express in DRG neurons. DRGs section were immunostained with primary 
antibodies against P2X3 and TRPV1. Neuronal profiles from each four mouse with ERǂKO, 
ERǃKO as well as wild type mice were quantified for each fluorescent probe.  Both P2X3 and 
TRPV1 receptors present in DRGs (Fig. 2).   
 
Fig. 2. Expression of P2X3 receptors in DRG neurons from wild type, ERǂKO, and  ERǃKO 
in vivo  
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In our next experiments we evaluated P2X3 receptors modulation by ATP and E2 in sensory 
neurons. DRG neurons were loaded with fluorescent dye Fura-2 AM for one hour at 37°C in 
HBSS supplemented with 20 mM HEPES, pH 7.4. The coverslips were placed on a stage of 
Olympus IX51 inverted microscope. A fast superfusion system was used to perfuse the cells 
with HBSS and rapidly apply E2 and other chemicals. Fluorescence intensity was captured 
as digital images (sampling rates of 0.1- 2s). Regions of interest were identified within the 
soma from which quantitative measurements were made by re-analysis of stored image 
sequences using Slidebook® Digital Microscopy software. [Ca2+]i was determined by 
ratiometric method. 
 
 
 
Fig. 3. 17 ǃ-Estradiol (E2) significantly reduced ATP-induced [Ca2+]i signaling in vitro. This 
effect was blocked by ER antagonist ICI 182 780 
3.2 Role of TRPV1 receptors in estrogen-induced nociceptive signaling in sensory 
neurons 
We found that nociceptive (small diameter) DRG neurons also express capsaicin-sensitive 
vanilloid (TRPV1) receptors. TRPV1positive neurons were categorized according to their 
labeling patterns and were expressed as a percentage of the total number of TRPV1 -positive 
cells.  Immunohistochemical signal from ERǂKO, ERǃKO and WT mice was measured by 
computerized image analysis (Fig. 4)  
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Fig. 4. Expression of TRPV1 receptors in dorsal root ganglion neurons from Wt, ERǂKO, and 
ERǃKO in vivo. 
Capsaicin-induced TPRV1 receptor-mediated changes in [Ca2+]i may represent a level of 
DRG activation to noxious cutaneous stimulation while ATP-induced changes in [Ca2+]i may 
reflect the level of DRG neuron sensitization to noxious visceral stimuli since ATP is 
released by noxious stimuli and tissue damage near the primary afferent nerve terminals . In 
the view of this fact, TRPV1 receptor expression and activity might be considered as 
markers for a specific subtype of sensory neurons, and their activation by exogenous stimuli 
(e.g. capsaicin) could be a useful tool to exam the possible modulatory effects of pain-related 
substances. 
3.3 Primary afferent sensory neurons receive input from different visceral organs 
An important test of our hypothesis will be to establish that E2 modulates visceral afferents. 
A corollary of that hypothesis was that cutaneous pain may be differently modulated 
compared with visceral pain. We have proposed that E2 preferentially acts on visceral 
afferents to modulate the nociception. In a series of experiments using retrograde tract 
 
  
                 FG staining                            TMR staining              Double (FG/TMR) staining 
     
Fig. 5. Identification of colon-specific (with FG), uterus-specific (with TMR) and DRG 
receiving input from both organs in vitro 
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tracing we identified cutaneous and visceral afferent neurons in vivo and in vitro. We  
also found a subset of DRG neurons which innervate both visceral organs: uterus and 
colon. 
4. Conclusion 
Endometriosis is one of the most common benign gynecological diseases, characterized by 
the presence of endometrial tissue outside the uterine cavity, most commonly implanted 
over visceral and peritoneal surfaces within the female pelvis. Clinical studies have 
shown that it may occur in up to 10-15% of women of reproductive age. Symptoms of 
endometriosis are usually associated with pelvic pain, including recurrent painful 
periods, painful intercourse, and painful defecation during menstruation, chronic lower 
abdominal pain and hypersensitivity. Unfortunately, understanding of the mechanisms  
of endometriosis-associated pain and its management in women is currently insufficient. 
Studies have shown possible mechanisms of chronic pelvic pain associated  
with endometriosis could be due to persistent nociceptive input from endometrial tissues 
that lead to peripheral and central sensitisation resulting in increased responsiveness of 
dorsal root ganglion and dorsal horn neurons. Indeed, recent studies in human and 
animals have shown that peritoneal endometrial lesions are richly innervated by Aδ and 
C sensory nerve fibers, which positively stained by substance P or calcitonin gene-related 
peptide.   
Several lines of evidence indicated that there is a close relationship between nerve fiber 
density and endometriosis-associated pain. There is a significant increase in nerve fiber 
density in women with endometriosis who reported pelvic pain, suggesting these nerve 
fibers may play an important role in the mechanisms of pain generation. Accumulating 
literatures described that SP presents in the myometrium and is involved in the 
inflammatory and pain responses, suggesting a possible role of SP nerve fibers in the 
generation of pain related to endometriosis. SP, which is synthesized and contained in 20–
30% of DRG neurons, is involved in the transmission of nociceptive information to the 
central nerve system. SP is contained primarily in, and co-released from, small-diameter 
primary afferent fibers on noxious stimulation. Activation of nociceptive C and Aδ 
primary afferent fibers by electrical, chemical, or mechanical stimulation has been 
reported to release SP. Visceral nociceptive C-fibers can be activated by SP, representing 
an endogenous system regulating inflammatory, immune responses, and visceral 
hypersensitivity. SP afferent fibers play an important role in the pathogenesis of visceral 
hyperalgesia, suggesting critical role of SP in regulation of pelvic nociception associated 
with endometriosis. ATP is a peripheral mediator of pain which contributes to the 
activation of sensory afferents by activating ATP receptors following inflammation or 
nerve injury. It may correlate with SP release and play an important role in modulating 
nociception in primary sensory neurons. Local injections of ATP and ATP analogs to the 
rat hindpaw elicit spontaneous pain behaviors, hyperalgesia and allodynia which can be 
augmented by inflammation, indicating ATP might be involved in visceral hyperalgesia 
associated with endometriosis. Although these findings reveal the greater abundance of 
primary sensory nerve fibers clearly present within the peritoneal endometrial lesions in 
patients diagnosed with endometriosis, and these nerve fibers may play an important role 
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in pain generation associated with endometriosis, pain mechanisms associated with 
endometriosis are still not well known, and the role of these primary sensory nerve fibers 
has not been specifically determined. 
Our data support the idea that E2 modulates nociceptive responses in pelvic pain 
syndromes such as endometriosis, however, whether E2 is pro- or anti-nociceptive 
remains unresolved.  Within the context of our hypothesis visceral nociception and 
nociceptor sensitization appear to be regulated by P2X3 and TRPV1.  E2 modulates DRG 
neurons response to ATP and capsaicin suggesting that visceral afferent nociceptors are 
modulated by E2 in the DRG. The DRG is an important site of visceral afferent 
convergence and cross-sensitization.  We have demonstrated that 17-ǃ estradiol (E2), the 
most common form of estrogen act on functional properties of P2X3 and TRPV1 receptors 
in DRG neurons in vitro. DRG neurons from Wt and knock-out mice responded to P2X3 
and TRPV1 activation. We also studied the long-term (chronic) exposure to E2 on sensory 
neurons that mimics the temporal pattern of circulating E2 levels in cycling female 
rodents which is equivalent to an E2 primal action on animal reproductive behavior. The 
localization of ER in DRG neurons and the attenuation of ATP/capsaicin- induce [Ca2+]i 
strongly suggest that E2 modulates visceral pain processing peripherally.  Moreover, E2 
appears to have different actions on nociceptive signaling depending on the input. Adult 
DRG neurons in short-term culture retain the expression of receptors (P2X and TRPV1) 
which mediate the response to putative nociceptive signals. They continue to respond to 
ER agonists mimicking in vivo activation. An important advantage is that these neurons 
can be studied apart from endogenous signals. Our data clearly showed the new role of 
nociceptors in pathophysiological aspects of chronic pelvic pain and potential way of 
designing future therapies. 
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